1. Changes in HDL cholesterol and cardiovascular outcomes after lipid modification therapy. Issue 10 (24th March 2012) Authors: Ray, Kausik; Wainwright, Nick W J; Visser, Loes; Witteman, Jacqueline; Breteler, Monique; Ambegaonkar, Baishali; Hofman, Albert; Stricker, Bruno; Wareham, Nick; Khaw, Kay Tee; Sandhu, Manjinder Journal: Heart Issue: Volume 98:Issue 10(2012) Page Start: 780 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Influence of CYP2C8 polymorphisms on imatinib steady-state trough level in chronic myeloid leukemia and gastrointestinal stromal tumor patients. Issue 6 (June 2017) Authors: Verboom, Michiel C.; Visser, Loes; Kouwen, Sander; Swen, Jesse J.; Diepstraten, Jeroen; Posthuma, Ward F.; Gelderblom, Hans; van Lammeren, Daniëlle; Wilms, Erik B. Journal: Pharmaocogenetics and genomics Issue: Volume 27:Issue 6(2017:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patient reporting of sexual adverse events on an online platform for medication experiences. Issue 12 (22nd July 2022) Authors: Gordijn, Rineke; Wessels, Wendela; Kriek, Esther; Nicolai, Melianthe P. J.; Elzevier, Henk W.; Visser, Loes; Guchelaar, Henk‐Jan; Teichert, Martina Other Names: Wong Ian guestEditor.; Dewildt Saskia guestEditor. Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 12(2022) Page Start: 5326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗